Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Canaccord Genuity starts Kistos at 'buy', highlights boost from Oman deal

(Sharecast News) - Canaccord Genuity initiated coverage of Kistos with a 'buy' rating and a 360p price target on Monday, saying the AIM‑listed oil and gas group was set for a step‑change in scale once its acquisition of Omani production completes later this year. The Canadian bank said Kistos had rapidly evolved from a start‑up into a diversified international producer with assets across the Netherlands, UK, Norway and soon Oman, supported by an experienced management team from RockRose Energy. It added that the shares looked "cheap", trading on an FY26 enterprise value-to-underlying earnings multiple of around 1.4x.

Canaccord Genuity described the Oman transaction as "transformative", with completion expected in Q326, and highlighted that the deal was forecast to double group output to more than 20,000 barrels of oil per day on a pro‑forma basis, while also significantly diversifying production away from the North Sea. Post‑completion, Oman was expected to account for roughly half of Kistos' production and a large share of its reserves and resources, with lighter capex requirements than its existing portfolio.

The broker said Kistos still saw growth potential in its current assets, including the Balder Next development in Norway and new drilling options in the UK, which could sustain production well into the next decade. It also highlighted plans to expand UK gas‑storage capacity by up to 60%, calling the midstream asset strategically important and undervalued by the market.

Canaccord noted Kistos' recent $300m Nordic bond issue had strengthened the balance sheet and pointed to "meaningful deleveraging potential", with net debt projected to fall from around $200m post‑Oman to roughly $115m by FY28. It also said the company could move into a net‑cash position before the end of the decade.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Berenberg raises target price on Persimmon, keeps 'hold' rating
(Sharecast News) - Analysts at Berenberg raised their target price on housebuilder Persimmon from 1,150p to 1,240p on Friday after lifting their 2026-27 earnings per share estimates by an average of 2% following the group's third-quarter trading update.
Wise H1 profits climb as customer base tops 16m
(Sharecast News) - Global fintech group Wise reported a jump in first-half revenue and profits on Friday, putting the recently dual-listed firm on track to hit the upper end of its full-year growth targets.
GSK wins positive CHMP opinion for Bexsero meningitis B booster
(Sharecast News) - Pharmaceutical giant GSK said on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use had issued a positive opinion recommending a label update for its Bexsero meningitis B vaccine.
Major Microsoft outage hits hospitals, businesses and financial markets worldwide
(Sharecast News) - A global Microsoft outage has disrupted businesses, government agencies and other organisations worldwide, leaving users without a slew of vital services in what is one of the group's most prolonged service disruptions in history.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.